Ekso Bionics (EKSO) stock price, revenue, and financials

Ekso Bionics market cap is $43.8 m, and annual revenue was $11.33 m in FY 2018

$43.8 M

EKSO Mkt cap, 12-Dec-2019

$3.3 M

Ekso Bionics Revenue Q3, 2019
Ekso Bionics Gross profit (Q3, 2019)1.8 M
Ekso Bionics Gross profit margin (Q3, 2019), %52.7%
Ekso Bionics Net income (Q3, 2019)206 K
Ekso Bionics EBIT (Q3, 2019)-3.8 M
Ekso Bionics Cash, 30-Sept-20198.1 M
Ekso Bionics EV36.7 M

Ekso Bionics Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

5.3m8.7m14.2m7.4m11.3m

Cost of goods sold

3.8m7.5m11.3m5.3m7.0m

Gross profit

1.6m1.2m2.9m2.1m4.3m

Gross profit Margin, %

29%14%21%28%38%

Sales and marketing expense

7.1m9.3m11.0m13.2m13.8m

R&D expense

3.9m6.5m8.9m9.5m5.8m

General and administrative expense

1.4k7.4m7.0m10.9m10.7m11.7m

Operating expense total

1.4k18.4m22.7m30.5m33.7m31.3m

EBIT

(12.3k)(16.8m)(21.6m)(27.6m)(31.6m)(27.0m)

EBIT margin, %

(315%)(249%)(194%)(430%)(239%)

Interest expense

61.0k5.0k166.0k2.5m38.0k

Interest income

6.0k11.0k12.0k

Pre tax profit

(33.6m)(19.6m)(23.5m)(29.1m)(27.0m)

Income tax expense

Net Income

(12.3k)(33.8m)(19.6m)(23.5m)(29.1m)(27.0m)

Quarterly

Ekso Bionics Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

29.2k25.2m19.6m16.8m27.8m7.7m

Accounts Receivable

1.5m2.1m2.8m3.7m

Prepaid Expenses

388.0k436.0k1.3m281.0k

Inventories

622.0k1.1m1.6m3.0m3.4m

Current Assets

29.3m25.2m20.7m34.9m15.0m

PP&E

2.1m2.6m2.4m2.2m2.4m

Goodwill

189.0k189.0k189.0k189.0k

Total Assets

29.2k33.5m32.2m24.4m38.0m17.7m

Accounts Payable

783.0k2.7m1.9m2.4m3.2m

Short-term debt

41.0k80.0k2.1m2.3m

Current Liabilities

6.6m8.6m6.3m9.2m10.1m

Long-term debt

77.0k4.8m2.6m

Total Debt

118.0k7.0m5.0m

Total Liabilities

14.1k10.7m23.4m17.9m16.6m14.9m

Common Stock

6.4k102.0k105.0k60.0k63.0k

Preferred Stock

Additional Paid-in Capital

94.5m100.1m121.3m165.8m173.9m

Retained Earnings

(16.9k)(71.8m)(91.4m)(114.9m)(144.2m)(171.1m)

Total Equity

15.1k22.8m8.8m6.5m21.4m2.7m

Financial Leverage

1.9 x1.5 x3.7 x3.7 x1.8 x6.5 x

Quarterly

USDQ2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

12.7k30.0k1.9k438.078.014.6m11.0m7.2m21.1m16.3m11.2m12.3m4.7m12.8m9.4m10.7m33.4m20.6m13.9m13.0m9.2m13.3m8.1m

Accounts Receivable

1.8m1.5m1.9m1.5m2.4m2.2m2.4m1.6m2.2m1.3m2.1m2.2m3.6m3.5m3.0m3.8m4.5m5.2m

Prepaid Expenses

407.0k401.2k447.0k473.0k726.0k738.0k692.0k533.0k689.0k597.0k2.1m958.0k584.0k509.0k506.0k606.0k428.0k

Inventories

1.1m1.3m864.4k838.0k1.2m1.2m2.5m2.4m1.9m1.8m1.9m2.4m2.8m2.4m3.4m3.3m3.7m3.3m

Current Assets

438.078.018.9m15.3m11.7m25.6m22.2m17.2m18.2m9.4m17.6m13.3m15.3m40.2m27.9m20.4m19.9m16.8m22.1m17.0m

PP&E

1.8m1.8m2.0m2.2m2.2m2.4m2.6m2.6m2.6m2.5m2.6m2.3m2.4m2.3m2.2m2.3m1.8m1.7m

Goodwill

189.0k189.0k189.0k189.0k189.0k189.0k189.0k189.0k189.0k189.0k189.0k189.0k

Total Assets

12.7k30.0k1.9k438.078.021.8m18.6m15.4m30.0m26.9m22.1m22.6m13.6m21.6m16.9m18.9m43.4m31.0m23.2m22.4m20.9m25.6m20.3m

Accounts Payable

4.2k1.0m1.2m1.1m1.5m2.3m2.1m3.6m2.1m1.4m2.9m2.1m990.0k3.4m2.6m3.4m2.5m2.5m1.4m

Short-term debt

39.3k40.0k42.0k43.0k79.0k81.0k78.0k67.0k432.0k972.0k1.6m2.3m2.3m2.3m2.3m2.3m2.3m

Current Liabilities

10.1k15.8k5.6m6.1m5.9m6.7m8.4m8.3m7.8m5.8m5.5m7.0m6.6m6.6m10.0m9.4m10.2m9.7m9.3m8.1m

Long-term debt

111.3k100.0k65.0k53.0k390.0k6.4m5.9m5.4m4.3m3.7m3.2m3.1m2.5m1.8m

Total Debt

150.7k140.0k107.0k96.0k469.0k81.0k78.0k67.0k6.4m5.9m5.4m6.6m6.1m5.5m5.4m4.8m972.0k

Total Liabilities

18.5k18.5k10.1k96.3m36.7m21.3m10.9m13.0m12.9m15.8m12.0m13.4m18.3m17.3m13.7m16.1m15.6m16.8m16.3m20.2m13.9m

Common Stock

5.0k6.0k6.4k6.4k6.4k78.5k78.5k102.0k102.0k102.0k109.0k16.0k21.0k22.0k26.0k60.0k60.0k61.0k63.0k68.0k75.0k75.0k

Preferred Stock

Additional Paid-in Capital

18.1k25.7k25.7k45.2m45.5m45.6m94.9m95.4m95.9m101.7m102.3m117.5m121.9m130.6m165.1m167.4m167.8m172.7m182.1m186.1m186.6m

Retained Earnings

(40.1k)(119.8m)(63.7m)(51.6m)(75.9m)(81.6m)(86.7m)(95.0m)(100.8m)(109.3m)(123.3m)(128.8m)(135.2m)(152.1m)(160.0m)(167.0m)(177.7m)(180.8m)(180.6m)

Total Equity

11.4k(8.1k)(9.6k)(15.7k)(74.5m)(18.1m)(5.9m)19.1m13.9m9.2m6.8m1.6m8.2m(1.4m)1.6m29.7m14.8m7.6m5.6m4.5m5.4m6.4m

Debt to Equity Ratio

-4.7 x3.6 x0.2 x0.2 x

Debt to Assets Ratio

0.4 x0.3 x0.1 x0 x

Financial Leverage

2.6 x-0.2 x0 x0 x-0.3 x-1 x-2.6 x1.6 x1.9 x2.4 x3.3 x8.7 x2.6 x-12.2 x11.6 x1.5 x2.1 x3 x4 x4.6 x4.7 x3.2 x

Ekso Bionics Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(12.3k)(33.8m)(19.6m)(23.5m)(29.1m)(27.0m)

Depreciation and Amortization

745.0k933.0k1.9m1.7m1.5m

Accounts Receivable

(1.0m)(520.0k)154.0k(1.1m)(850.0k)

Inventories

354.0k(200.0k)(541.0k)(2.1m)(1.7m)

Accounts Payable

300.0(716.0k)1.7m(818.0k)77.0k752.0k

Cash From Operating Activities

(12.0k)(15.0m)(18.3m)(25.0m)(31.2m)(22.2m)

Purchases of PP&E

(1.5m)(1.5m)(1.1m)(456.0k)(131.0k)

Cash From Investing Activities

(1.5m)(1.5m)(1.1m)(456.0k)(131.0k)

Short-term Borrowings

(2.6m)(60.0k)(79.0k)(54.0k)(2.2m)

Cash From Financing Activities

32.7k40.9m14.1m23.3m42.6m2.3m

Net Change in Cash

20.7k24.4m(5.6m)(2.7m)11.0m(20.2m)

Interest Paid

138.0k5.0k33.0k20.0k18.0k

Income Taxes Paid

38.0k12.0k16.0k429.0k457.0k

Quarterly

USDQ2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Net Income

(6.1k)(7.9k)(23.2k)(24.7k)(30.8k)(81.8m)(25.6m)(13.6m)(4.1m)(9.8m)(14.9m)(3.7m)(9.4m)(17.9m)(8.3m)(13.8m)(20.1m)(7.9m)(15.9m)(22.9m)(6.6m)(9.6m)(9.4m)

Depreciation and Amortization

156.9k333.4k535.4k200.0k419.0k653.0k440.0k908.0k1.4m475.0k881.0k1.3m428.0k888.0k1.2m275.0k548.0k594.0k

Accounts Receivable

(1.2m)(944.3k)(1.4m)94.0k(845.0k)(636.0k)(314.0k)503.0k(131.0k)498.0k(382.0k)(488.0k)(798.0k)(678.0k)(109.0k)(188.0k)(931.0k)(1.6m)

Inventories

(494.7k)(573.4k)(160.7k)(261.0k)(478.0k)(379.0k)(1.5m)(1.3m)(1.0m)(470.0k)(836.0k)(1.2m)(286.0k)(198.0k)(1.3m)(154.0k)(260.0k)195.0k

Accounts Payable

(4.0k)4.2k(454.4k)(272.0k)(422.3k)681.0k1.5m1.4m924.0k(620.0k)(1.3m)988.0k328.0k(750.0k)1.0m210.0k1.1m(660.0k)(654.0k)(1.8m)

Cash From Operating Activities

(9.9k)(11.7k)(27.2k)(28.7k)(30.6k)(5.6m)(8.7m)(12.3m)(3.8m)(8.5m)(13.1m)(6.8m)(14.1m)(20.6m)(7.3m)(16.9m)(25.6m)(6.7m)(12.8m)(17.0m)(5.2m)(9.7m)(14.3m)

Purchases of PP&E

(248.4k)(674.9k)(917.4k)(281.0k)(559.0k)(962.0k)(285.0k)(597.0k)(728.0k)(138.0k)(248.0k)(353.0k)(31.0k)(31.0k)(51.0k)(7.0k)(60.0k)(60.0k)

Cash From Investing Activities

(144.7k)(571.1k)(813.7k)(281.0k)(559.0k)(962.0k)(285.0k)(597.0k)(728.0k)(138.0k)(248.0k)(353.0k)(31.0k)(31.0k)(51.0k)(7.0k)(60.0k)(60.0k)

Short-term Borrowings

(2.5m)(2.5m)(2.5m)(11.0k)(22.0k)(40.0k)(19.0k)(56.0k)(58.0k)(22.0k)(38.0k)(46.0k)(399.0k)(994.0k)(1.6m)(591.0k)(1.2m)(1.8m)

Cash From Financing Activities

14.2k33.2k1.5k19.5m19.4m19.5m52.0k82.0k92.0k(164.0k)(172.0k)14.5m2.0k10.9m42.5m(399.0k)(994.0k)2.4m6.8m15.4m14.8m

Net Change in Cash

4.3k21.5k(27.2k)(28.7k)(29.1k)13.8m10.2m6.4m(4.1m)(8.9m)(14.0m)(7.2m)(14.9m)(6.8m)(7.4m)(6.1m)16.6m(7.2m)(13.9m)(14.8m)1.6m5.6m403.0k

Interest Paid

130.3k133.7k136.1k350.0k96.0k183.0k255.0k

Income Taxes Paid

1.8k1.8k1.7k238.0k8.0k8.0k

Ekso Bionics Ratios

USDY, 2019

EV/EBIT

-9.7 x

EV/CFO

-2.6 x

Debt/Equity

0.2 x

Financial Leverage

3.2 x

Ekso Bionics Employee Rating

4.218 votes
Culture & Values
4.3
Work/Life Balance
3.9
Senior Management
3.4
Salary & Benefits
3.6
Career Opportunities
3.6
Source